By Admin at 18 Apr 2016
Toxins in wasp venom could be used to create an entirely new class of anti-cancer drugs. The wasp, Polybia paulista, wards off predators by injecting them with venom rich in Polybia-MP1 (MP1), a toxin with known anti-cancer properties.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial
